Richard Steinhart
Director of Finance/CFO at BIOXCEL THERAPEUTICS, INC.
Net worth: 14 510 $ as of 2024-04-29
Profile
Richard I.
Steinhart is an Independent Director at Atossa Therapeutics, Inc. since 2014, an Independent Director at Actinium Pharmaceuticals, Inc. since 2013, and the Chief Financial & Accounting Officer, Senior VP at BioXcel Therapeutics, Inc. since 2017.
He previously worked as an Independent Director at TG Therapeutics, Inc. from 2004 to 2012, a Managing Director at Forest Street Capital, LLC from 1992 to 2006, and a Managing Director at SAE Ventures.
He also served as the Chief Financial Officer & Vice President at Emisphere Technologies, Inc. from 1991 to 1992, the CFO, Secretary, Treasurer & Senior VP-Finance at STRATA Skin Sciences, Inc. from 2006 to 2013, and the Chief Financial Officer & General Partner at CW Group, Inc. from 1991 to 1992.
Additionally, he was the Chief Financial Officer & Vice President at Remedy Pharmaceuticals, Inc. from 2015 to 2017 and the Chief Financial Officer & SVP-Finance at MELA Sciences Inc. from 2012 to 2013.
Mr. Steinhart holds an undergraduate degree and an MBA from Pace University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-03 | 4,765 ( 0.01% ) | 12 437 $ | 2024-04-29 | |
| 2023-12-27 | 316 ( 0.00% ) | 2 073 $ | 2024-04-29 | |
| 2024-03-14 | 0 ( -.--% ) | - $ | 2024-04-29 |
Richard Steinhart active positions
| Companies | Position | Start |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director/Board Member | 2013-11-07 |
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | 2014-03-02 |
| BIOXCEL THERAPEUTICS, INC. | Director of Finance/CFO | 2017-09-30 |
Former positions of Richard Steinhart
| Companies | Position | End |
|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Director of Finance/CFO | 2017-03-31 |
| STRATA SKIN SCIENCES, INC. | Director of Finance/CFO | 2013-12-30 |
| TG THERAPEUTICS, INC. | Director/Board Member | 2011-12-31 |
| Forest Street Capital, LLC | Corporate Officer/Principal | 2006-04-23 |
| EMISPHERE TECHNOLOGIES, INC. | Director of Finance/CFO | 1992-04-30 |
Training of Richard Steinhart
| Pace University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| STRATA SKIN SCIENCES, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
| Forest Street Capital, LLC | |
| SAE Ventures | |
| MELA Sciences Inc. |
- Stock Market
- Insiders
- Richard Steinhart
